Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients

Am J Hypertens. 2017 Nov 1;30(11):1106-1111. doi: 10.1093/ajh/hpx104.

Abstract

Background: Prognosis of masked and white coat uncontrolled hypertension (MUCH and WCUCH, respectively) detected by ambulatory blood pressure (BP) monitoring is incompletely clear in elderly treated hypertensive patients. We evaluated prognosis of MUCH and WCUCH identified by ambulatory BP monitoring in this setting.

Methods: The occurrence of a composite endpoint was evaluated in 1,191 elderly treated hypertensive patients. Controlled hypertension (CH) was defined as clinic BP <140/90 mm Hg and 24-hour BP <130/80 mm Hg, MUCH as clinic BP <140/90 mm Hg and 24-hour BP ≥130 and/or ≥80 mm Hg, WCUCH as clinic BP ≥140 and/or ≥90 mm Hg and 24-hour BP <130/80 mm Hg and sustained uncontrolled hypertension (SUCH) as clinic BP ≥140 and/or ≥90 mm Hg and 24-hour BP ≥130 and/or ≥80 mm Hg.

Results: MUCH was identified in 142 patients (12% of all the population, 34% of those with normal clinic BP) and WCUCH in 230 patients (19% of all the population, 30% of those with high clinic BP). During the follow-up (9.1 ± 4.9 years, range 0.4-20 years), 392 events occurred. After adjustment for various covariates, patients with MUCH (hazard ratio (HR) 1.60, 95% confidence interval (CI) 1.12-2.29, P = 0.01) and SUCH (HR 1.81, 95% CI, 1.35-2.42, P < 0.001) had significantly higher cardiovascular risk than those with CH, whereas those with WCUCH (HR 1.09, 95% CI, 0.74-1.60, P = 0.66) had not significantly higher risk.

Conclusions: In elderly treated hypertensive patients evaluated by ambulatory BP monitoring, compared to individuals with CH, those with MUCH have significantly higher risk and those with WCUCH have slightly and not significantly higher risk.

Keywords: ambulatory blood pressure; blood pressure; cardiovascular risk; hypertension; masked uncontrolled hypertension; white coat uncontrolled hypertension.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Aging
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects*
  • Blood Pressure Monitoring, Ambulatory*
  • Databases, Factual
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Masked Hypertension / diagnosis*
  • Masked Hypertension / drug therapy*
  • Masked Hypertension / physiopathology
  • Middle Aged
  • Predictive Value of Tests
  • Time Factors
  • Treatment Outcome
  • White Coat Hypertension / diagnosis*
  • White Coat Hypertension / drug therapy*
  • White Coat Hypertension / physiopathology

Substances

  • Antihypertensive Agents